Amplia Therapeutics Ltd
ATX•Health Care•Biotechnology•Last updated: Dec 25
About
Amplia Therapeutics Ltd is a biotechnology company focused on the development of new drugs for the treatment of cancer and fibrotic diseases. The company is advancing its pipeline with a focus on its lead drug candidates targeting focal adhesion kinase (FAK) inhibitors. Amplia's operations are centered around research and development activities aimed at progressing these candidates through clinical trials.
Share Price Chart
Company Details
- Sector
- Health Care
- Industry
- Biotechnology
- ASX Code
- ATX
Related Shares
Investor Resources
Should you buy Amplia Therapeutics Ltd right now?
While ATX looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now